Similar articles

• A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates.

  Monden M, Gotoh M, Kanai T, Valdivia LA, Umeshita K, Endoh W, Nakano Y, Kawai M, Ohzato H, Ukei T, et al. Monden M, et al. Transplant Proc. 1990 Feb;22(1):66-71. Transplant Proc. 1990. PMID: 1689904 No abstract available.
• Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts.

  Flavin T, Ivens K, Wang J, Gutierrez J, Hoyt EG, Billingham M, Morris RE. Flavin T, et al. Transplant Proc. 1991 Feb;23(1 Pt 1):531-2. Transplant Proc. 1991. PMID: 1703701 No abstract available.
• Pancreaticoduodenal allotransplantation with FK 506 in the dog.

  Morimoto T, Yamada F, Kobayashi T, Miyaishi S, Tokumaru T, Kamiya I, Takagi H. Morimoto T, et al. Transplant Proc. 1990 Apr;22(2):717-9. Transplant Proc. 1990. PMID: 1691550 No abstract available.
• Clinical use of FK 506 in liver transplantation.

  Klintmalm GB. Klintmalm GB. Transplant Proc. 1996 Apr;28(2):974-6. Transplant Proc. 1996. PMID: 8623484 Review.
• Cyclosporine and tacrolimus: a comparison of immunosuppressants used for liver transplantation.

  Shultz SL, Meriney DK. Shultz SL, et al. Dimens Crit Care Nurs. 1996 Jul-Aug;15(4):187-97. Dimens Crit Care Nurs. 1996. PMID: 8717641 Review.